Richard Black

Dr. Richard Black

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
DSDror Seliktar
Dror Seliktar
RBRichard Black
Richard Black
RVRaymond P. Vito
Raymond P. Vito
RNRobert M. Nerem
Robert M. Nerem

11 January 2012 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
KMK. N. Margaris
K. N. Margaris
RBRichard Black
Richard Black
The lymphatic system is a vital part of the circulatory and immune systems, and plays an important role in homeostasis by controlling extracellular fluid volume and in combating infection. Nevertheless, there is a notable disparity in terms of research effort expended in relation to the treatment of lymphatic diseases in contrast to the cardiovascular system. While similarities to the cardiovascular system exist, there are considerable differences in their anatomy and physiology. This review outlines some of the challenges and opportunities for those engaged in modelling biological systems. The study of the lymphatic system is still in its infancy, the vast majority of the models presented in the literature to date having been developed since 2003. The number of distinct models and their variants are few in number, and only one effort has been made thus far to study the entire lymphatic network; elements of the lymphatic system such as the nodes, which act as pumps and reservoirs, have not been addressed by mathematical models. Clearly, more work will be necessary in combination with experimental verification in order to progress and update the knowledge on the function of the lymphatic system. As our knowledge and understanding of its function increase, new and more effective treatments of lymphatic diseases are bound to emerge.

1 August 2004 in Biomaterials
Verified
Journal Article
Closed access
ZTZ.G. Tang
Z.G. Tang
RBRichard Black
Richard Black
JCJ.M. Curran
J.M. Curran
John A. HuntJohn A. Hunt
John A. Hunt
NRN.P. Rhodes
N.P. Rhodes
DWD.F. Williams
D.F. Williams

1 October 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
IBIvan J. Hall Barrientos
Ivan J. Hall Barrientos
EPEleonora Paladino
Eleonora Paladino
PSPeter Szabó
Peter Szabó
SBSarah Brozio
Sarah Brozio
PHPeter J. Hall
Peter J. Hall
Dimitrios A. LamprouDimitrios A. Lamprou
Dimitrios A. Lamprou
For the creation of scaffolds in tissue engineering applications, it is essential to control the physical morphology of fibres and to choose compositions which do not disturb normal physiological function. Collagen, the most abundant protein in the human body, is a well-established biopolymer used in electrospinning compositions. It shows high in-vivo stability and is able to maintain a high biomechanical strength over time. In this study, the effects of collagen type I in polylactic acid-drug electrospun scaffolds for tissue engineering applications are examined. The samples produced were subsequently characterised using a range of techniques. Scanning electron microscopy analysis shows that the fibre morphologies varied across PLA-drug and PLA-collagen-drug samples - the addition of collagen caused a decrease in average fibre diameter by nearly half, and produced nanofibres. Atomic force microscopy imaging revealed collagen-banding patterns which show the successful integration of collagen with PLA. Solid-state characterisation suggested a chemical interaction between PLA and drug compounds, irgasan and levofloxacin, and the collagen increased the amorphous regions within the samples. Surface energy analysis of drug powders showed a higher dispersive surface energy of levofloxacin compared with irgasan, and contact angle goniometry showed an increase in hydrophobicity in PLA-collagen-drug samples. The antibacterial studies showed a high efficacy of resistance against the growth of both E. coli and S. Aureus, except with PLA-collagen-LEVO which showed a regrowth of bacteria after 48h. This can be attributed to the low drug release percentage incorporated into the nanofibre during the in vitro release study. However, the studies did show that collagen helped shift both drugs into sustained release behaviour. These ideal modifications to electrospun scaffolds may prove useful in further research regarding the acceptance of human tissue by inhibiting the potential for bacterial infection.

1 May 2005 in Biomaterials
Verified
Journal Article
Closed access
PFP. Feugier
P. Feugier
RBRichard Black
Richard Black
John A. HuntJohn A. Hunt
John A. Hunt
THT.V. How
T.V. How